Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd banner
J

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076

Watchlist Manager
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076
Watchlist
Price: 31.93 CNY 2.8% Market Closed
Market Cap: ¥10.1B

Intrinsic Value

The intrinsic value of one Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd stock under the Base Case scenario is 37.57 CNY. Compared to the current market price of 31.93 CNY, Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd is Undervalued by 15%.

Intrinsic Value
37.57 CNY
Undervaluation 15%
Intrinsic Value
Price
J
Worst Case
Base Case
Best Case

Valuation History
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd.

Explain Valuation
Alternatives to Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd

Wall St
Price Targets

Dividends

Shareholder Yield

Competitive Landscape

What is the Intrinsic Value of one Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd stock?

The intrinsic value of one Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd stock under the Base Case scenario is 37.57 CNY.

Is Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 31.93 CNY, Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd is Undervalued by 15%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett